This paper is in the following e-collection/theme issue:

Scoping Review Protocols (156) Pharmacology and Pharmaceutics (49)

Published on in Vol 9, No 9 (2020): September

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/17684, first published .
The Impact of Brexit on the Pharmaceutical Supply Chain of the United Kingdom: Scoping Review Protocol

The Impact of Brexit on the Pharmaceutical Supply Chain of the United Kingdom: Scoping Review Protocol

The Impact of Brexit on the Pharmaceutical Supply Chain of the United Kingdom: Scoping Review Protocol

Authors of this article:

Madison Milne-Ives1 Author Orcid Image ;   Ching Lam1 Author Orcid Image ;   Michelle van Velthoven1 Author Orcid Image ;   Edward Meinert1, 2, 3 Author Orcid Image
Article Authors Cited by (3) Tweetations (3) Metrics

Journals

  1. Valdes D, Alqazlan L, Procter R, Dale J. Global evidence on the rapid adoption of telemedicine in primary care during the first 2 years of the COVID-19 pandemic: a scoping review protocol. Systematic Reviews 2022;11(1) View
  2. Fadil A, Davis P, Geraghty J. A Mixed-Method Approach to Determine the Successful Factors Affecting the Criticality Level of Intermediate and Final Products on National Basis: A Case Study from Saudi Arabia. Sustainability 2023;15(7):6023 View
  3. Parkes J, Dodhia V, Ziter S, Olson N, Ghose A, Cracknell A, Wendy Ng H. Post COVID availability of oncology drugs – Is this the new normal on both sides of the Atlantic?. Journal of Oncology Pharmacy Practice 2023;29(8):2045 View